Royal Bank Of Canada Novo Nordisk A S Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Novo Nordisk A S stock. As of the latest transaction made, Royal Bank Of Canada holds 5,460,733 shares of NVO stock, worth $481 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

5,460,733

Previous 6,004,120 9.05%

Holding current value

$481 Million

Previous $715 Million 34.29%

% of portfolio

0.1%

Previous 0.15%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $46.2 Million - $65.2 Million	-543,387 Reduced 9.05%	5,460,733 $470 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $12.2 Million - $14.9 Million	102,132 Added 1.73%	6,004,120 $715 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $49.7 Million - $59.5 Million	405,231 Added 7.37%	5,901,988 $842 Million
Q1 2024 Nov 05, 2024	SELL	$102.11 - $135.92 $41.4 Million - $55.1 Million	-405,231 Reduced 6.87%	5,496,757 $706 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $176 Million - $234 Million	1,722,038 Added 45.62%	5,496,757 $706 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $11.6 Million - $13.9 Million	131,658 Added 3.61%	3,774,719 $390 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $183 Million - $402 Million	2,015,829 Added 123.88%	3,643,061 $331 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $7.18 Million - $7.95 Million	46,060 Added 2.91%	1,627,232 $263 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $20.2 Million - $24.3 Million	-152,741 Reduced 8.81%	1,581,172 $252 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $320,981 - $423,582	3,130 Added 0.18%	1,733,913 $235 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $9.11 Million - $11.2 Million	-95,567 Reduced 5.23%	1,730,783 $172 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $1.22 Million - $1.43 Million	11,774 Added 0.65%	1,826,350 $204 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $1.99 Million - $2.4 Million	21,370 Added 1.19%	1,814,576 $202 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $9.53 Million - $11.6 Million	99,354 Added 5.87%	1,793,206 $201 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $5.3 Million - $6.7 Million	62,829 Added 3.85%	1,693,852 $163 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $110 Million - $138 Million	1,631,023 New	1,631,023 $137 Million

Others Institutions Holding NVO

# of Institutions

1,881

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Novo Nordisk A S Transaction History